|
시장보고서
상품코드
2053217
바이오시뮬레이션 시장 : 제품 및 서비스별, 용도별, 유통 채널별, 지역별Biosimulation Market, By Product and Services, By Application, By Distribution Channel, By Geography |
||||||
바이오시뮬레이션 시장은 2026년에 32억 7,410만 달러에 달하고, 2033년까지 103억 6,780만 달러에 이를 것으로 예상되고 있습니다. 2026-2033년 CAGR은 17.9%를 나타낼 전망입니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2025년 | 시장 규모(2026년) | 32억 7,410만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간 CAGR(2026-2033년) | 17.90% | 예측 금액(2033년) | 103억 6,780만 달러 |
바이오시뮬레이션이란, 컴퓨터 시뮬레이션을 활용하여 인체의 생물학적 과정, 시스템 및 경로를 시뮬레이션하는 데 사용되는 계산 모델입니다. 이는 신체가 분자 및 세포 수준에서 어떻게 기능하는지, 그리고 의약품이나 의료기기 등 특정 의료적 개입이 체내에서 어떻게 작용할 수 있는지를 이해하는 데 도움이 됩니다. 질환의 메커니즘과 진행 과정, 그리고 분자에서 조직에 이르는 다양한 규모에서의 치료 개입과의 상호작용을 시뮬레이션함으로써, 바이오시뮬레이션은 의약품 개발 과정에서 대규모 실험실 시험 및 임상시험의 필요성을 줄이는 데 기여합니다. 이를 통해 비용 절감, 효율 향상, 그리고 신약 개발의 가속화가 실현됩니다.
시장 역학
세계 바이오시뮬레이션 시장의 성장은 제약 및 생명공학 업계의 연구개발비 증가, 의약품 개발 비용 및 기간 단축에 대한 관심 고조, 맞춤형 의료의 확산, 만성 질환 유병률 상승, 그리고 바이오시뮬레이션 분야의 급속한 기술 발전과 같은 요인들에 의해 주도되고 있습니다. 그러나 복잡한 바이오시뮬레이션 도구와 모델을 다루는 데 필요한 충분한 IT 인프라와 숙련된 전문 인력의 부족으로 인해 시장 성장이 저해될 가능성이 있습니다. 이 시장의 주요 기회는 백신 개발, 식이·독성 분석, 조직 공학, 맞춤형 의료 등을 포함한 바이오시뮬레이션의 응용 분야 확대와, 기술의 추가적인 발전을 위한 산업계와 학술 기관 간의 지속적인 협력에 있습니다.
최근 전 세계 바이오시뮬레이션 시장은 눈부신 기술적 진보를 이루고 있으며, 이는 새로운 기회와 응용 분야를 창출하고 있습니다. 생물 시뮬레이션은 컴퓨터를 이용한 모델링과 시뮬레이션을 통해 생물학적 과정을 연구하고 예측하는 것입니다. 이를 통해 연구자들은 세포, 조직, 나아가 생물 전체와 같은 생물학적 시스템을 시뮬레이션하여 질병에 대한 이해를 높이고, 새로운 약물 치료법을 시험해 볼 수 있게 됩니다.
본 보고서의 주요 특징
- 본 보고서는 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안에 대한 매트릭스를 설명하고 있습니다.
- 또한 시장 성장 촉진요인 및 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 관한 중요한 분석도 제공합니다.
- 전 세계 바이오시뮬레이션 시장의 주요 기업 프로파일을 다양한 지표(기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적, 전략 등)를 바탕으로 소개합니다.
- 본 보고서의 인사이트를 바탕으로 마케팅 담당자와 기업 경영진은 향후 제품 출시, 제품 라인업 개편, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있습니다.
- '세계의 바이오시뮬레이션 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자는 세계의 바이오시뮬레이션 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 할 수 있습니다.
목차
제1장 분석 목적 및 전제 조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 바이오시뮬레이션 시장 : 제품 및 서비스별(2021-2033년)
제5장 세계의 바이오시뮬레이션 시장 : 용도별(2021-2033년)
제6장 세계의 바이오시뮬레이션 시장 : 유통 채널별(2021-2033년)
제7장 세계의 바이오시뮬레이션 시장 : 지역별(2021-2033년)
제8장 경쟁 구도
제9장 섹션
KTH 26.06.17Biosimulation Market is estimated to be valued at USD 3,274.1 Mn in 2026 and is expected to reach USD 10,367.8 Mn by 2033, growing at a compound annual growth rate (CAGR) of 17.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 3,274.1 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 17.90% | 2033 Value Projection: | USD 10,367.8 Mn |
Biosimulation is a computational model that is used to simulate biological processes, systems, and pathways of the human body using computer simulations. It aids in understanding how the body functions at molecular and cellular levels and how certain medical interventions such as drugs or medical devices are likely to behave in it. By simulating disease mechanisms, progressions and their interaction with therapeutic interventions at various scales from molecule to tissue, biosimulation aids in reducing the need for extensive laboratory and clinical testing during drug development processes. This leads to lower costs, greater efficiency, and faster drug discovery.
Market Dynamics
Global biosimulation market growth is driven by factors such as rising R&D expenditure in pharmaceutical and biotechnology industries, growing emphasis on reducing drug development costs and time, increasing adoption of personalized medicine, growing prevalence of chronic diseases, and rapid technological advancements in field of biosimulation. However, the market growth can be restrained due to lack of competent IT infrastructure and skilled professionals required for handling complex biosimulation tools and models. Major opportunity for this market lies in growing application areas of biosimulation including vaccine development, dietary and toxicity analysis, tissue engineering, personalized medicine, and others and ongoing collaborations between industries and academic institutions for further advancement of technology.
Global biosimulation market has witnessed tremendous technological progress in the recent years, and this offers new opportunities and applications. Biosimulation uses computer modeling and simulation to study and predict biological processes. It allows researchers to simulate biological systems like cells, tissues and entire organisms to better understand disease and test new drug treatments.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global biosimulation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Certara, L.P., Simulations Plus, Inc., Dassault Systemes (Accelrys), Genedata AG, LeadScope, Inc., Compugen Inc., Schrodinger, LLC, In Silico Biosciences, Inc., Advanced Chemistry Development, Inc., Chemical Computing Group ULC, Physiomics PLC, and Pharmaceutical Product Development, LLC (Evidera)
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global biosimulation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biosimulation market
Market Segmentation
- By Product and Services (Revenue, USD Mn, 2021 - 2033)
- Software
- Services
- By Application (Revenue, USD Mn, 2021 - 2033)
- Drug Discovery
- Drug Development
- By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Certara, L.P.
- Simulations Plus, Inc.
- Dassault Systemes (Accelrys)
- Genedata AG
- LeadScope, Inc.
- Compugen Inc.
- Schrodinger, LLC
- In Silico Biosciences, Inc.
- Advanced Chemistry Development, Inc.
- Chemical Computing Group ULC
- Physiomics PLC
- Pharmaceutical Product Development, LLC (Evidera).
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Biosimulation Market Snippet, By Product and Services
- Global Biosimulation Market Snippet, By Application
- Global Biosimulation Market Snippet, By Distribution Channel
- Global Biosimulation Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Biosimulation Market, By Product and Services, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
5. Global Biosimulation Market, By Application, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Drug Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Drug Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
6. Global Biosimulation Market, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
7. Global Biosimulation Market, By Region, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2021 - 2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Mn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Certara, L.P.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Simulations Plus, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Dassault Systemes (Accelrys)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Genedata AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- LeadScope, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Compugen Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Schrodinger, LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- In Silico Biosciences, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Advanced Chemistry Development, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Chemical Computing Group ULC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Physiomics PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Pharmaceutical Product Development, LLC (Evidera)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
9. Section
- Research Methodology
- About us
